$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Alimera Sciences, Inc.
(NASDAQ : ALIM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Loading ALIM News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-2.17%78.041.3%$792.98m
BIIBBiogen Inc.
0.08%308.421.2%$595.42m
AMGNAmgen Inc.
0.02%172.001.1%$507.89m
CELGCelgene Corporation
-0.40%108.360.8%$478.59m
MDVNMedivation, Inc.
-0.06%80.301.5%$456.77m
REGNRegeneron Pharmaceuticals, Inc.
-0.38%401.453.4%$310.05m
ILMNIllumina, Inc.
-0.84%170.774.2%$210.93m
ALXNAlexion Pharmaceuticals, Inc.
-0.66%128.782.7%$185.58m
BMRNBioMarin Pharmaceutical Inc.
0.39%96.594.2%$184.54m
VRTXVertex Pharmaceuticals Incorporated
0.06%97.152.2%$112.26m
INCYIncyte Corporation
0.64%81.562.5%$106.99m
IONSIonis Pharmaceuticals, Inc.
-1.20%30.5311.4%$95.60m
AAgilent Technologies, Inc.
1.12%47.850.9%$94.73m
EXASExact Sciences Corporation
2.35%19.6422.9%$88.23m
TSROTESARO, Inc.
-0.71%85.8516.2%$88.03m

Company Profile

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. It focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its portfolio includes ILUVIEN and NADPH Oxidase Inhibitors. The company was founded on June 4, 2003 by C. Daniel Myers and David R. Holland and is headquartered in Alpharetta, GA.